Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3)

被引：3

作者：

Sekiguchi, Haruka ^{[1
]}

Kuroyanagi, Tomoko ^{[1
]}

Rhainds, David ^{[2
,3
]}

Kobayashi, Kazuya ^{[4
]}

Kobayashi, Yuka ^{[1
]}

Ohno, Hiroaki ^{[1
]}

Heveker, Nikolaus ^{[2
,3
]}

Akaji, Kenichi ^{[4
]}

Fujii, Nobutaka ^{[1
]}

Oishi, Shinya ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan

[2] Univ Montreal, Dept Biochim, Montreal, PQ H3T 1J4, Canada

[3] Univ Montreal, St Justine Hosp, Res Ctr, Montreal, PQ H3T 1C5, Canada

[4] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078412, Japan

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 61卷 / 08期

基金：

加拿大健康研究院;

关键词：

CXCR4/CXCR7/CXCL12; PATHWAY; CXCR4; ANTAGONISTS; PROSTATE-CANCER; MIGRATION; CXCL12/SDF-1; TC14012; GROWTH; CELLS; RDC1;

D O I：

10.1021/acs.jmedchem.8b00336

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The atypical chemokine receptor 3 (ACKR3)/CXC chemokine receptor 7 (CXCR7) recognizes stromal cell derived factor 1 (SDF-1)/CXCL12 and is involved in a number of physiological and pathological processes. Here, we investigated the SAR of the component amino acids in an ACKR3-selective ligand, FC313 [cyclo(-D-Tyr-L-Arg-L-MeArgL-Nal(2)-L-Pro-)], for the development of highly active ACKR3 ligands. Notably, modification at the L-Pro position with toward ACKR3. a bulky hydrophobic side chain led to improved bioactivity toward ACKR3.

引用

页码：3745 / 3751

页数：7

共 50 条

[41] Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands
Huang, YS
Luedtke, RR
Freeman, RA
Wu, L
Mach, RH
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) : 1815 - 1826
[42] Structure-based quantitative structure-activity relationship modeling of estrogen receptor β-ligands
Dong, Xialan
Hilliard, Solomon G.
Zheng, Weifan
FUTURE MEDICINAL CHEMISTRY, 2011, 3 (08) : 933 - 945
[43] Structure-activity relationship study of 2-and 3-substituted quinuclidines as ligands for cholinergic receptors.
Zhao, CL
Zhang, M
Gabriel, JL
Caldwell, WS
Bencherif, M
Canney, DJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A94 - A94
[44] Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopainine receptor 3 (D3) ligands
Ji, M
Chen, JY
Ding, K
Wu, XH
Varady, J
Levant, B
Wang, SM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) : 1701 - 1705
[45] Structure-Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands
Pockes, Steffen
Wifling, David
Buschauer, Armin
Elz, Sigurd
CHEMISTRYOPEN, 2019, 8 (03): : 285 - 297
[46] Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands
Gao, H
Williams, C
Labute, P
Bajorath, J
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1999, 39 (01): : 164 - 168
[47] Structure-Activity Relationship Studies of Hydantoin-Cored Ligands for Smoothened Receptor
Liu, Yang
Zhou, Fang
Ding, Kang
Xue, Dongxiang
Zhu, Zhihao
Li, Cuixia
Li, Fei
Xu, Yueming
Xu, Fei
Le, Zhiping
Zhao, Suwen
Tao, Houchao
CHEMISTRYOPEN, 2021, 10 (10): : 1028 - 1032
[48] Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands
Engelhardt, Harald
de Esch, Iwan J. P.
Kuhn, Daniel
Smits, Rogier A.
Zuiderveld, Obbe P.
Dobler, Julia
Mayer, Moriz
Lips, Sebastian
Arnhof, Heribert
Scharn, Dirk
Haaksma, Eric E. J.
Leurs, Rob
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 54 : 660 - 668
[49] Structure-function relationship between the human chemokine receptor CXCR3 and its ligands
Clark-Lewis, I
Mattioli, I
Gong, JH
Loetscher, P
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) : 289 - 295
[50] The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers
Freitas, Christelle
Desnoyer, Aude
Meuris, Floriane
Bachelerie, Francoise
Balabanian, Karl
Machelon, Veronique
CYTOKINE & GROWTH FACTOR REVIEWS, 2014, 25 (03) : 307 - 316

← 1 2 3 4 5 →